Advertisement

Topics

Search Results for "Asahi Kasei A Bpep"

06:59 EST 21st February 2017 | BioPortfolio

Matching Channels

None

Matching News

Basilea licenses isavuconazole to Asahi Kasei in Japan

Swiss drugmaker Basilea Pharmaceutica has entered into a partnering agreement with Asahi Kasei Pharma…

Asahi Kasei Corporation Strategy, SWOT and Corporate Finance Report Prices from USD $175

SummaryAsahi Kasei Corporation Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy...

Evotec enters into an integrated drug discovery collaboration with Asahi Kasei Pharma

Evotec AG announced it has entered into an integrated drug discovery collaboration on an ion channel target with Asahi Kasei Pharma Corporation, a wholly owned subsidiary of Asahi Kasei Corporation, T...

Evotec and Asahi Kasei up drug discovery collaboration

German CRO Evotec says it will invest in its staff and infrastructure to help service a drug discovery deal with Japan’s Asahi Kasei Pharma.

BRIEF-Evotec and Asahi Kasei Pharma enter drug discovery collaboration

* Entered into an integrated drug discovery collaboration with Asahi Kasei Pharma Corporation Source text for Eikon: Further company coverage:

Asahi Kasei Pharma Corporation Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350

SummaryMarketLine's Company Mergers Acquisitions MA, Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an orga...

Asahi Kasei Pharma America Corp. formerly Artisan Pharma, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report Prices from USD $350

SummaryMarketLine's Company Mergers Acquisitions MA, Partnerships Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an orga...

Basilea licensed Asahi Kasei Pharma rights to isavuconazole in Japan

Basilea Pharmaceutica International Ltd. licensed Asahi Kasei Pharma Corp. exclusive rights to develop and commercialize the antifungal drug isavuconazole in Japan.

Matching PubMed Articles

None

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement